HomeCompareTSVT vs EQR

TSVT vs EQR: Dividend Comparison 2026

TSVT yields 40.00% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSVT wins by $191.4K in total portfolio value
10 years
TSVT
TSVT
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full TSVT calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — TSVT vs EQR

📍 TSVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSVTEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSVT + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSVT pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSVT
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, TSVT beats the other by $30,057.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSVT + EQR for your $10,000?

TSVT: 50%EQR: 50%
100% EQR50/50100% TSVT
Portfolio after 10yr
$136.2K
Annual income
$21,500.32/yr
Blended yield
15.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

TSVT
Analyst Ratings
4
Buy
6
Hold
Consensus: Hold
Price Target
$3.50
-30.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-1.0
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSVT buys
0
EQR buys
0
No recent congressional trades found for TSVT or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSVTEQR
Forward yield40.00%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$231.9K$40.5K
Annual income after 10y$39,181.04$3,819.61
Total dividends collected$174.4K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$3.50$70.35

Year-by-year: TSVT vs EQR ($10,000, DRIP)

YearTSVT PortfolioTSVT Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$14,700$4,000.00$11,248$547.57+$3.5KTSVT
2$21,224$5,495.33$12,701$666.53+$8.5KTSVT
3$30,125$7,415.26$14,405$814.59+$15.7KTSVT
4$42,071$9,836.48$16,413$999.84+$25.7KTSVT
5$57,854$12,838.17$18,795$1,232.92+$39.1KTSVT
6$78,403$16,499.54$21,639$1,527.95+$56.8KTSVT
7$104,788$20,897.28$25,057$1,903.80+$79.7KTSVT
8$138,226$26,102.79$29,197$2,385.87+$109.0KTSVT
9$180,082$32,179.61$34,250$3,008.70+$145.8KTSVT
10$231,869$39,181.04$40,467$3,819.61+$191.4KTSVT

TSVT vs EQR: Complete Analysis 2026

TSVTStock

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Full TSVT Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this TSVT vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSVT vs SCHDTSVT vs JEPITSVT vs OTSVT vs KOTSVT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.